#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatobiliary cancer Duchenne muscular dystrophy gene carrier Alternating hemiplegia of childhood Dermatitis Facioscapulohumeral muscular dystrophy T-cell type acute leukaemia Narcolepsy Germ cell cancer White matter lesion Deafness bilateral Bronchopulmonary dysplasia Chronic myeloid leukaemia (in remission) Neoplasm malignant Neuroblastoma recurrent Congenital megacolon More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Osteosarcoma recurrent – Trials in Disease Lymphatic malformation Breast angiosarcoma – Basic Information Andersen-Tawil syndrome – Trials in Disease Mantle cell lymphoma refractory Focal segmental glomerulosclerosis – Life with Disease Mantle cell lymphoma refractory – Trials in Disease Alagille syndrome – Trials in Disease Nephroblastoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Riboflavin Sodium Phosphate Vincristine Sulfate Maribavir Opevesostat Calcitriol AGANIRSEN Glpg3667 Fumarate Other Immunosuppressants Dermatophagoides Pteronyssinus GSKVX000000030825 AZD4360 Dazostinag ABY-271 Teplizumab Mps-103 Betula Alba Pollen Extract Melatonin TALADEGIB Enpatoran HYALURONIDASE More therapies…

    Learn about Your Condition

    Injury Obsessive-compulsive disorder Myeloid leukaemia Transplant rejection Labour pain Hypomagnesaemia Retinal neovascularisation Basal cell carcinoma Glycogen storage disorder Affective disorder Gallbladder cancer Metastases to rectum Biliary cancer metastatic Endocarditis bacterial Hypoaesthesia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Fondation A De Rothschild

Fondation A De Rothschild

29 Rue Manin, Paris, 75019, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Glenzocimab for Patients with Acute Ischemic Stroke Undergoing Mechanical Thrombectomy

    Not recruiting

    4 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Glenzocimab
    France

  • Study on the Effects of Bosentan for Patients with Early Stage Non-Arteritic Anterior Ischemic Optic Neuropathy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Optic ischaemic neuropathy
    Investigated Drugs:
    • Bosentan
    France

  • Study on Bevacizumab Injections for Patients with Coats’ Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Exudative retinopathy
    Investigated Drugs:
    • Bevacizumab
    France

  • Study on the Effect of Aflibercept Injections in Patients with Central Retinal Vein Occlusion (CRVO) and Spontaneous Retinal Arterial Pulsations (SRAPs)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Retinal vein occlusion
    Investigated Drugs:
    • Aflibercept
    France

  • Study on the Effectiveness and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin
    • Nipocalimab
    Czechia France Germany Greece Italy Poland +2

  • Study on Glenzocimab for Patients with Large Ischemic Stroke Eligible for Endovascular Therapy

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Gadobutrol
    • Glenzocimab
    France

  • Study Comparing Aflibercept and Placebo for Patients with Macular Telangiectasia Type 1

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Macular telangiectasia
    Investigated Drugs:
    • Aflibercept
    France

  • Study of Danicopan for Patients with Geographic Atrophy Due to Age-Related Macular Degeneration

    Not recruiting

    2 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Danicopan
    Czechia France Germany Hungary Italy Latvia +2

  • Study on the Effectiveness and Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a 36-Week Refill System

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    Austria Belgium France Germany Italy Spain

  • Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

    Not recruiting

    3 1
    Investigated Drugs:
    • Asundexian
    Austria Belgium Bulgaria Czechia Denmark Finland +14
Previous Page
1 … 5 6 7 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!